Japan based Daiichi Sankyo Company, Limited announced that it has entered into a clinical trial collaboration agreement ...
Marinomed Biotech AG, a globally operating biopharmaceutical company based in Vienna, is entering the Italian market for...
Japan based Eisai Co., Ltd. has announced that its U.S. subsidiary Eisai Inc. has launched its in-house discovered orexi...
Daewoong has announced that the company signed a partnership with Inventage Lab, a drug delivery system platform startup...
Kolmar Korea has announced that it would sell its pharmaceutical business unit and Kolmar Pharma, a subsidiary of the co...
The Supervisory Board of Eppendorf AG has appointed Axel Jaeger as the company's new Chief Financial Officer (CFO). The ...
China headquartered Luye Pharma Group held a special signing ceremony as part of the "We Care About Mental Health" initi...
Japanese firm Astellas Pharma Inc. has announced that the Japan Ministry of Health, Labour and Welfare (MHLW) has approv...
Boehringer Ingelheim and Eli Lilly and Company have announced an academic research collaboration with the Duke Clinical ...
Japanese firm Daiichi Sankyo Company, Limited has announced the launch of ENHERTU® (trastuzumab deruxtecan), a HER2 ...
In an in-depth review of the market and having evaluated the collective developments from this year’s Pharmapack e...
Australia based Mayne Pharma Group Limited is pleased to announce the launch of butalbital acetaminophen and caffeine (B...
Lincoln Pharmaceuticals Limited, one of India's leading healthcare companies has received the European Union (EU) GMP ce...
Japan based Eisai Co., Ltd. announced that it has launched New Selbelle Premium Tablets and New Selbelle Premium Fine Gr...
Japan based Shionogi & Co., Ltd. has announced that Shionogi has officially made the decision to develop a prophylac...
A fully integrated biopharmaceutical company Uni-Bio Science Group Limited announced on 15 May 2020 that its wholly...
CPhI and P-MEC China – co-organized by Informa Markets, CCCMHPIE and Sinoexpo Informa Markets – will ho...
Novartis announced on 6 May 2020 that the US Food and Drug Administration (FDA) approved Tabrecta™&n...
Gilead Sciences has struck a licensing agreement with five generic drugmakers to make antiviral drug remdesivir for...
Gilead Sciences, Inc. has announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has grante...
Freudenberg Medical, a global contract manufacturer of medical device components and pharmaceutical tubing, announces th...
Daiichi Sankyo Company, Limited and AstraZeneca’s ENHERTU® (fam-trastuzumab deruxtecan-nxki) has been granted ...
ZYUS Life Sciences Inc., a Canada based company dedicated to improving quality of life through research and leadership i...
The CoVIg-19 Plasma Alliance, an unprecedented plasma industry collaboration recently established to accelerate the deve...
For the first time, Romaco’s latest product developments are being unveiled to trade specialists in the company&rs...
